Lab
CBS Labs of Tampa LLC
CBS Labs of Tampa LLC was paid $125K by Medicaid between Dec 2021 and Nov 2024, across 44 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 25% of everything it billed.
33Billing provider infoCBS LABS OF TAMPA LLC
TAMPA, FL 33607
TAMPA, FL 33607
33aNPI1861939183assigned 01/24/2017
33bProvider typeClinical Medical Laboratory
28Total paid$125K
24GClaims66,769
24DCodes billed44
24AFirst – last monthDec 2021 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#97 of 225
Median peer was paid$74K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 14 | $0.00 | |
| 2022 | 1,271 | $173.65 | |
| 2023 | 29,189 | $58K | |
| 2024incomplete | 36,295 | $66K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 25% | 2,624 | 1,889 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 4,398 | 3,178 | $19K |
| 87186 | 12% | 1,420 | 944 | $15K | |
| 80061 | Lipid panel | 6.0% | 4,812 | 3,562 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5.6% | 714 | 437 | $7K |
| 80053 | Comprehensive metabolic panel | 4.6% | 6,066 | 4,393 | $6K |
| 87481 | 3.9% | 602 | 432 | $5K | |
| 84153 | 3.6% | 716 | 515 | $4K | |
| 82607 | 3.2% | 3,091 | 2,173 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 6,394 | 4,574 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.7% | 4,241 | 3,113 | $3K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 2.4% | 5,981 | 4,225 | $3K |
32 more codes
| 82746 | 1.1% | 2,508 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,535 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 40 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $1K |
| 87634 | <1% | 39 | $876.27 | |
| 87500 | <1% | 486 | $740.09 | |
| 81001 | <1% | 1,567 | $727.09 | |
| 87640 | <1% | 554 | $692.26 | |
| 83970 | <1% | 62 | $648.38 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,836 | $606.07 |
| 82728 | <1% | 1,331 | $598.66 | |
| 84439 | <1% | 1,433 | $541.93 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 156 | $533.44 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 311 | $529.57 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 89 | $502.17 |
| 81003 | <1% | 855 | $481.58 | |
| 84466 | <1% | 1,385 | $474.87 | |
| 87581 | <1% | 40 | $404.86 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,101 | $373.23 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 26 | $367.50 |
| 87088 | <1% | 1,428 | $358.70 | |
| 84550 | <1% | 392 | $339.10 | |
| 82570 | <1% | 88 | $310.79 | |
| 82140 | <1% | 180 | $279.17 | |
| 83540 | <1% | 1,483 | $258.43 | |
| 80164 | <1% | 286 | $218.16 | |
| 87653 | <1% | 343 | $178.00 | |
| 85045 | <1% | 1,034 | $79.77 | |
| 84481 | <1% | 19 | $38.51 | |
| 84154 | <1% | 25 | $6.23 | |
| 82044 | <1% | 17 | $1.07 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBAINA, MARIO (PRESIDENT)